<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="443404" id="root" date="1997-03-14" xml:lang="en">
<title>USA: PharmChem Laboratories Q4 shr nil vs loss.</title>
<headline>PharmChem Laboratories Q4 shr nil vs loss.</headline>
<dateline>MENLO PARK, Calif 1997-03-14</dateline>
<text>
<p>(000's omitted except per share amounts)</p>
<p>			    Three Months Ended  Twelve Months Ended</p>
<p>					Dec. 31,		Dec. 31,</p>
<p>				    1996	1995	1996     1995</p>
<p> Sales			   $9,986  $10,290   $41,255  $39,111</p>
<p> Cost of sales		  7,885    8,160    31,757   29,771</p>
<p> Gross profit		   2,101    2,130     9,498    9,340</p>
<p>Operating expenses and</p>
<p>  goodwill amortization     2,027    2,658     9,080    8,827</p>
<p>Income (loss) before</p>
<p>restructuring and other</p>
<p>  charges and taxes		74    (528)	 418	513</p>
<p>Restructuring and other</p>
<p>  charges			    --    8,775	  --    8,775</p>
<p>Income (loss) from</p>
<p>  operations			 74  (9,303)	 418  (8,262)</p>
<p> Interest expense		  85	111	 435	457</p>
<p> Other (income) expense, net    2     (25)	(63)     (89)</p>
<p>					 87	 86	 372	368</p>
<p>Income (loss) before income</p>
<p>  taxes			    (13)  (9,389)	  46  (8,630)</p>
<p> Benefit from income taxes     --  (2,123)	  --  (1,819)</p>
<p> Net income (loss)	     (13)  (7,266)	  46  (6,811)</p>
<p>Net income (loss) per share</p>
<p>				     0.00   (1.31)	0.01   (1.23)</p>
<p> Weighted average shares    5,682    5,574     5,710    5,542</p>
<p>NOTES: 1995 year included a loss of $6,811,000, or $1.23 per share, including a pre-tax provision of $8,775,000 for restructuring and other unusual charges relating principally to write-down of certain assets and severance costs, and an increase of $675,000 in allowance for doubtful accounts and other accruals. These charges reduced 1995 after tax earnings by $7,300,000 or $1.32 per share.</p>
<p>Full company name is PharmChem Laboratories Inc.</p>
<p>-- New York Newsdesk 212 859-1610</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
  <code code="C1511">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-14"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-03-14"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-03-14"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MENLO PARK, Calif"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
